StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ACROUD.ST$0.16+5.88%
Fair $0.16+0.0%

ACROUD.ST

Acroud AB (publ)

Consumer Cyclical / GamblingStockholm

$0.16

+0.01 (+5.88%)

Fairly Valued+0.0%Fair Value $0.16Fund rank 28/100 · Data gapFallback financials|
SA 35/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $2.0M · quality 50.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 52/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -30.0%, below the 5% threshold
Thesis & Journal · ACROUD.STLocal privado en este navegador · Acroud AB (publ)
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$207M

P/E

N/A

•

EV/EBITDA

192.5x

↑

ROE

-30.0%

↓

Gross Margin

N/A

•

Debt/Equity

0.70

↑
52-Week Range$0
$0$0

TradingView lightweight chart

ACROUD.ST price, volumen y niveles de valoración

Último $0.162Periodo -94.0%
Fair value: $0.162

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+14.5%

FCF CAGR

-44.0%

FCF margin

1.2%

FCF / Net income

-0.11x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $46.4M · net income $-5.1M · FCF $545000.0

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

-1.1%-16.7% pts

Net margin

-11.1%+48.5% pts

FCF margin

1.2%-8.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$46.4M$46.4M$38.6M$39.4M$30.9M
Net Income$-5.1M$-5.1M$-3.3M$-31.7M$-18.4M
EBITDA$1.1M$1.1M$5.5M$-22.2M$-11.1M
EPS-0.00-0.00-0.01-0.21-0.14
Gross Margin——100.0%100.0%102.7%
Operating Margin-1.1%-1.1%5.8%2.0%15.6%
Net Margin-11.1%-11.1%-8.6%-80.6%-59.6%
Balance Sheet
Debt/Equity0.700.70-22.666.530.82
Current Ratio1.351.35———
Cash Flow
Free Cash Flow$545000.00$545000.00$3.6M$2.0M$3.1M
Returns
ROE-30.0%-30.0%439.2%-1154.1%-75.7%
Valuation
EV/EBITDA192.46192.4610.95——
P/B12.1012.10—91.0914.07
Growth & Yield
Revenue Growth20.2%20.2%-1.9%27.3%—
EPS Growth73.3%73.3%92.9%-48.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +11.7%

Total return

+11.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.01 → -0.00

Residual

+11.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+11.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.